CVE-2026-113716virtualenv: Builtin creation follows linked environment directories
Updated under an hour ago ()
Does this affect you?
It affects pypa virtualenv. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
virtualenv is a tool for creating isolated virtual python environments. Prior to 21.14.9, the builtin creator calls ensure_dir() for executable, library, and package directories, and ensure_dir() accepts an existing symlink to a directory because exists() follows it. Interpreter creation, seed installation, and activation generation then write through the linked parent outside the requested destination when another local account prepared the tree and the invoking user can access the target. The --clear option removes the planted tree first, while ordinary creation reaches it; arbitrary attacker-selected output bytes are not established. This issue is fixed in version 21.14.9.
- CVSS
- 4.5 MEDIUM (v3.1, CNA)CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:L/I:L/A:L
- Weakness (CWE)
- CWE-59
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- GitHub_M
- NVD analysis
- Received
- Record last updated
- Oct 21, 2026
- First seen by InfoSec Signals
- Oct 20, 2026
Affected products
pypa virtualenv pypa:virtualenv (from the name) | before 21.14.9 | CNA record |
References
- https://github.com/pypa/virtualenv/security/advisories/GHSA-cw65-gx24-rc82x-refsource-confirm
- https://github.com/pypa/virtualenv/pull/3429x-refsource-misc
- https://github.com/pypa/virtualenv/commit/554d9f9d4f7758f5cf53f993031e29787f1f74c5x-refsource-misc
- https://github.com/pypa/virtualenv/releases/tag/21.14.9x-refsource-misc
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.